Provided by Tiger Trade Technology Pte. Ltd.

Evolent Health

3.02
+0.03001.00%
Post-market: 3.020.00000.00%19:52 EDT
Volume:2.66M
Turnover:8.07M
Market Cap:337.03M
PE:-0.60
High:3.09
Open:3.03
Low:3.01
Close:2.99
52wk High:12.07
52wk Low:2.50
Shares:111.60M
Float Shares:86.94M
Volume Ratio:0.90
T/O Rate:3.06%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.0732
EPS(LYR):-5.0732
ROE:-66.54%
ROA:-0.12%
PB:0.81
PE(LYR):-0.60

Loading ...

Evolent posts Q4 net loss attributable to common shareholders of USD 429.1 million (91.6%)

Reuters
·
Feb 25

Evolent Health sees FY26 revenue $2.4B-$2.6B, consensus $2.38B

TIPRANKS
·
Feb 25

BRIEF-Evolent Health Q4 Revenue USD 468.719 Million Vs. IBES Estimate USD 468.8 Million

Reuters
·
Feb 25

Evolent Health Q4 Revenue USD 468.719 Million VS. Ibes Estimate USD 468.8 Million

THOMSON REUTERS
·
Feb 25

Evolent Health Expects Revenue for FY to Be in the Range of About $2.4 Billion to $2.6 Billion

THOMSON REUTERS
·
Feb 25

Evolent Health Inc: Expects to Deploy About $25 Mln to $35 Mln in Cash for Capitalized Software Development During 2026

THOMSON REUTERS
·
Feb 25

Evolent Health Q4 Adjusted Ebitda Margin 8.1%

THOMSON REUTERS
·
Feb 25

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Feb 24

Evolent Health Inc. kündigt Veröffentlichung von Finanzzahlen an

Reuters
·
Feb 05

Evolent Health Is Maintained at Buy by BTIG

Dow Jones
·
Feb 02

Evolent Health Inc : Btig Cuts Target Price to $10 From $16

THOMSON REUTERS
·
Feb 02

Evolent Health Is Maintained at Buy by Citigroup

Dow Jones
·
Jan 10

Evolent Health price target lowered to $6 from $9.50 at Citi

TIPRANKS
·
Jan 09

Evolent Health Inc : RBC Resumes Coverage With Sector Perform Rating; Target Price $5

THOMSON REUTERS
·
Jan 09

Evolent Health Is Maintained at Market Outperform by Citizens

Dow Jones
·
Jan 06

Evolent Health Inc. Files Initial Statement of Beneficial Ownership for Chief Financial Officer Mario Ramos

Reuters
·
Jan 06

BRIEF-Evolent Reports Inducement Award Under NYSE Listing Rule 303A.08

Reuters
·
Jan 03

Evolent Reports Inducement Award Under Nyse Listing Rule 303a.08

THOMSON REUTERS
·
Jan 03

Syra Health Names Gregory R. Alexander as CEO

Reuters
·
Dec 18, 2025

Evolent Health Inc. Files Initial Beneficial Ownership Statement for Director Jill D. Smith

Reuters
·
Dec 13, 2025